02/06/2025
3:06 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
9:09 AM | VANGUARD GROUP INC (Filed by)
X4 Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
5:15 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:18 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:21 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:22 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for XFOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for X4 Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/16/2025
3:45 PM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:50 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:02 AM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:11 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
5:12 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:15 PM | VANGUARD GROUP INC (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2024
3:54 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:07 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:44 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:56 PM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/11/2024
3:01 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:28 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:40 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:17 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
7:01 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
7:09 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:58 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
5:28 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
7:30 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
5:30 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:30 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:20 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:08 PM | X4 Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
6:43 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Has Trump finally met his match? (Ad) Dylan Jovine predicted the 2008 financial crisis over a year in advance. His readers had a chance to lock in gains as high as 459%, 646%, even 700% - all while the stock market got cut in half. Now he's warning investors that the recent AI sell-off could be a harbinger of another massive market crash. Could he be right again? Click here for his emergency broadcast... |
03/11/2024
4:19 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:19 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:20 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:16 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
4:52 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4/A | |
